FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to nucleic acid containing regulatory polynucleotide containing minimal promotor and from one to twenty of AARE (amino acid response element) nucleic acids, and nucleic acid encoding Cas nuclease that is under control of the specified regulatory polynucleotide. The invention also relates to a vector, a particle, a cell and a composition containing the above-mentioned nucleic acid, and a method for genome editing using the specified composition.
EFFECT: invention is effective for controlled expression of nucleic acid encoding Cas nuclease in at least one target cell in an individual.
13 cl, 7 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT ADEN-ASSOCIATED VIRUS, WHICH IS HYBRID OF AAV9 AND AAVrh74 SEROTYPES, WITH REDUCED TROPISM FOR LIVER TISSUE | 2019 |
|
RU2812279C2 |
ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS | 2018 |
|
RU2794996C2 |
METHODS AND COMPOSITIONS FOR TREATING TUMORS | 2017 |
|
RU2741786C2 |
GENE EDITING OF DEEP INTRON MUTATIONS | 2016 |
|
RU2759335C2 |
MODIFICATION OF B-CELLS | 2018 |
|
RU2783116C2 |
PaCas9 NUCLEASE | 2018 |
|
RU2706298C1 |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DISEASES ASSOCIATED WITH TUBULIN CARBOXYPEPTIDASES (TCP) | 2018 |
|
RU2812207C2 |
VECTOR, METHOD FOR TREATING CHOROIDITIS, METHOD FOR SELECTIVE EXPRESSION OF POLYNUCLEOTIDE | 2014 |
|
RU2723101C2 |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH TUBULIN CARBOXYPEPTIDASES (TCP) | 2018 |
|
RU2797200C1 |
VARIANTS OF ACID ALPHA-GLUCOSIDASE AND THEIR USE | 2017 |
|
RU2780410C2 |
Authors
Dates
2022-05-04—Published
2017-06-02—Filed